Champions Oncology (CSBR) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -115.29% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 62.26% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 211.46% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 172.35% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 188.66% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 83.98% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -195.19% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 28.17% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -195.19% |
| Apr 30, 2026 | -134.25% |
| Jan 31, 2026 | -410.04% |
| Oct 31, 2025 | -1,210.87% |
| Jul 31, 2025 | 97.08% |
| Apr 30, 2025 | 455.84% |
| Jan 31, 2025 | 142.87% |
| Oct 31, 2024 | -121.43% |
| Jul 31, 2024 | 105.22% |
| Apr 30, 2024 | -21.15% |
| Jan 31, 2024 | -227.59% |
| Oct 31, 2023 | -76.73% |
| Jul 31, 2023 | -453.11% |
| Apr 30, 2023 | -599.02% |
| Jan 31, 2023 | -79.11% |
| Oct 31, 2022 | 253.51% |
| Jul 31, 2022 | -37.74% |
| Apr 30, 2022 | 111.16% |
| Jan 31, 2022 | 448.75% |
| Oct 31, 2021 | -51.37% |